Treponema pallidum Nucleic Acid, PCR
Runt Related Transcription Factor 1 (RUNX1) Gene Mutation Analysis
Eosinophilic esophagitis
Oncotype DX, Breast Cancer
Factor V (Leiden) Mutation
Bilirubin, Direct, Serum
Adiponectin
Inhibin A
Glucose-6-Phosphate Dehydrogenase (G6PD), Screen
von Willebrand Factor Multimer Analysis, Plasma
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
Interpretation
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now
Loading...